Your search returned 15 results.

Results
	1.	Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies. [electronic resource] by Meulien, Didier Huizar, Karin Brecher, Martin Producer: 20100614 In: Human psychopharmacology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study. [electronic resource] by Lindenmayer, Jean-Pierre Brown, David Liu, Sherry Brecher, Martin Meulien, Didier Producer: 20120327 In: Psychopharmacology bulletin vol. 41 Availability: No items available. Save to lists Add to cart (remove)
	3.	A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned. [electronic resource] by Cutler, Andrew J Tran-Johnson, Tram Kalali, Amir Aström, Mikael Brecher, Martin Meulien, Didier Producer: 20120302 In: Psychopharmacology bulletin vol. 43 Availability: No items available. Save to lists Add to cart (remove)
	4.	Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis. [electronic resource] by Mueller, Sebastian Luderer, Mathias Zhang, Doris Meulien, Didier Brach, Björn Steiniger Schou, Maiken Brix Producer: 20201026 In: Alcohol and alcoholism (Oxford, Oxfordshire) vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence. [electronic resource] by Higuchi, Susumu Takahashi, Masayoshi Murai, Yoshiyuki Tsuneyoshi, Kana Nakamura, Izuru Meulien, Didier Miyata, Hisatsugu Producer: 20210609 In: Psychiatry and clinical neurosciences vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia. [electronic resource] by Möller, Hans-Jürgen Johnson, Sunny Mateva, Temenuzhka Brecher, Martin Svensson, Ola Miller, Frank Meulien, Didier Producer: 20080507 In: International clinical psychopharmacology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients. [electronic resource] by Peuskens, Joseph Trivedi, Jitendra Malyarov, Sergiy Brecher, Martin Svensson, Ola Miller, Frank Persson, Inger Meulien, Didier Producer: 20110714 In: Psychiatry (Edgmont (Pa. : Township)) vol. 4 Availability: No items available. Save to lists Add to cart (remove)
	8.	Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial. [electronic resource] by Miyata, Hisatsugu Takahashi, Masayoshi Murai, Yoshiyuki Tsuneyoshi, Kana Hayashi, Takako Meulien, Didier Sørensen, Per Higuchi, Susumu Producer: 20200424 In: Psychiatry and clinical neurosciences vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care. [electronic resource] by Castera, Philippe Stewart, Edmund Großkopf, Josef Brotons, Carlos Brix Schou, Maiken Zhang, Doris Steiniger Brach, Björn Meulien, Didier Producer: 20190405 In: European addiction research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. [electronic resource] by Kahn, René S Schulz, S Charles Palazov, Veselin D Reyes, Efren B Brecher, Martin Svensson, Ola Andersson, Henrik M Meulien, Didier Producer: 20070719 In: The Journal of clinical psychiatry vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [electronic resource] by Newcomer, John W Ratner, Robert E Eriksson, Jan W Emsley, Robin Meulien, Didier Miller, Frank Leonova-Edlund, Julia Leong, Ronald W Brecher, Martin Producer: 20090630 In: The Journal of clinical psychiatry vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials. [electronic resource] by Grossberg, George T Kohegyi, Eva Mergel, Victor Josiassen, Mette Krog Meulien, Didier Hobart, Mary Slomkowski, Mary Baker, Ross A McQuade, Robert D Cummings, Jeffrey L Producer: 20210120 In: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. [electronic resource] by Anton, Raymond F Litten, Raye Z Falk, Daniel E Palumbo, Joseph M Bartus, Raymond T Robinson, Rebecca L Kranzler, Henry R Kosten, Thomas R Meyer, Roger E O'Brien, Charles P Mann, Karl Meulien, Didier Producer: 20120417 In: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. [electronic resource] by Falk, Daniel E O'Malley, Stephanie S Witkiewitz, Katie Anton, Raymond F Litten, Raye Z Slater, Megan Kranzler, Henry R Mann, Karl F Hasin, Deborah S Johnson, Bankole Meulien, Didier Ryan, Megan Fertig, Joanne Producer: 20200214 In: JAMA psychiatry vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study. [electronic resource] by Quelch, Darren R Mick, Inge McGonigle, John Ramos, Anna C Flechais, Remy S A Bolstridge, Mark Rabiner, Eugenii Wall, Matthew B Newbould, Rexford D Steiniger-Brach, Björn van den Berg, Franz Boyce, Malcolm Østergaard Nilausen, Dorrit Breuning Sluth, Lasse Meulien, Didier von der Goltz, Christoph Nutt, David Lingford-Hughes, Anne Producer: 20180226 In: Biological psychiatry vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)